People · Operator
Named in public records as an officer, director or promoter · active 2011–2024 · Healthtech, Other Technology, Biotechnology
| Company | Role | Sector | Stage | Raised · real | Value · est | Tied |
|---|---|---|---|---|---|---|
| Vertos Medical Inc | — | Healthtech | Series C | $177.3M | $514.0M | 2011 |
| Illumitex, Inc. | — | Other Technology | Series B | $68.6M | $213.2M | 2014 |
| Dnatrix Inc | — | Biotechnology | Series B | $30.7M | $616.3M | 2014 |
| Recourse Biologics, Inc. | — | Biotechnology | Seed | $2.8M | $11.8M | 2024 |
Daniel Watkins at the center, the companies they're named on, and every other operator named alongside them — an interlock map of shared founding teams, boards and funds. Name-matched, so treat as a research lead.
People named alongside Daniel Watkins on the same companies — an interlock signal (shared founding team, board, or fund). Name-matched, so verify before acting.
| Operator | Shared | Their companies |
|---|---|---|
| Daniel M. Watkins | 3 | 5 |
| Harry M Ross | 2 | 2 |
| John Ryan | 1 | 17 |
| Forest Baskett | 1 | 15 |
| Andrew Firlik | 1 | 14 |
| Bruce Feuchter | 1 | 12 |
| Ittai Harel | 1 | 6 |
| Myles Greenberg | 1 | 6 |
| Daniel Pelak | 1 | 5 |
| GREGORY OBERHOLTZER | 1 | 3 |
| Forest M. Baskett | 1 | 3 |
| Hugo Harrod | 1 | 3 |
| James Corbett | 1 | 3 |
| James Treybig | 1 | 3 |
| Tom Foody | 1 | 3 |
| Armando Pauker | 1 | 3 |
| Robert Kuhling | 1 | 3 |
| Andrew M Firlik | 1 | 2 |
| John M. Ryan | 1 | 2 |
| Ed Zysik | 1 | 2 |
People are matched by normalized name across records; a common name may merge distinct individuals. Treat as a research lead, the same way modeled valuations are directional, not quoted.